ModiQuest Research


For over 10 years ModiQuest Research specializes in the generation of monoclonal antibodies against difficult targets for R&D, diagnostic and therapeutic applications. Using our proprietary ModiVacc™ (hyper-immune stimulatory cell immunization), ModiFuse™ (electrofusion-based hybridoma generation), ModiSelect™ (antigen-specific B-cell selection) and ModiPhage™ (phage display) technologies, we can generate monoclonal antibodies from multiple species against virtually any target. Besides lead antibody generation, we also provide antibody engineering such as affinity maturation and humanization (ModiTune™), and production in transient and stable mammalian cell systems (ModiXpress™). All services are offered on a fee-for-service basis